The immunohistochemical staining for the remaining preoperative biopsy tissues also showed that the tumor cells were reactive to CD21, CD23, and CD35(Fig. 2f), supporting the diagnosis of FDCS of bladder. This evidence concerns the gene FCER2 and neoplasm.